Synageva BioPharma Corp (NASDAQ:GEVA)

98.73
Delayed Data
As of Feb 27
 -0.69 / -0.69%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.40%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close99.42
Today’s open98.89
Day’s range96.08 - 103.30
Volume329,150
Average volume (3 months)306,970
Market cap$3.6B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-26.70%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-1.63-5.51%
BLUEbluebird bio Inc-0.90-0.94%
JUNOJuno Therapeutics In...-0.68-1.43%
XONIntrexon Corp-1.86-4.33%
Data as of 4:03pm ET, 02/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account